The Future of Cardiovascular Medicine From the Regulatory Perspective.
Publication
, Journal Article
Califf, RM
Published in: J Am Coll Cardiol
August 16, 2016
Duke Scholars
Published In
J Am Coll Cardiol
DOI
EISSN
1558-3597
Publication Date
August 16, 2016
Volume
68
Issue
7
Start / End Page
766 / 769
Location
United States
Related Subject Headings
- Regenerative Medicine
- Humans
- Evidence-Based Medicine
- Cardiovascular System & Hematology
- Cardiovascular Diseases
- Cardiology
- Biomarkers
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Califf, R. M. (2016). The Future of Cardiovascular Medicine From the Regulatory Perspective. J Am Coll Cardiol, 68(7), 766–769. https://doi.org/10.1016/j.jacc.2016.07.001
Califf, Robert M. “The Future of Cardiovascular Medicine From the Regulatory Perspective.” J Am Coll Cardiol 68, no. 7 (August 16, 2016): 766–69. https://doi.org/10.1016/j.jacc.2016.07.001.
Califf RM. The Future of Cardiovascular Medicine From the Regulatory Perspective. J Am Coll Cardiol. 2016 Aug 16;68(7):766–9.
Califf, Robert M. “The Future of Cardiovascular Medicine From the Regulatory Perspective.” J Am Coll Cardiol, vol. 68, no. 7, Aug. 2016, pp. 766–69. Pubmed, doi:10.1016/j.jacc.2016.07.001.
Califf RM. The Future of Cardiovascular Medicine From the Regulatory Perspective. J Am Coll Cardiol. 2016 Aug 16;68(7):766–769.
Published In
J Am Coll Cardiol
DOI
EISSN
1558-3597
Publication Date
August 16, 2016
Volume
68
Issue
7
Start / End Page
766 / 769
Location
United States
Related Subject Headings
- Regenerative Medicine
- Humans
- Evidence-Based Medicine
- Cardiovascular System & Hematology
- Cardiovascular Diseases
- Cardiology
- Biomarkers
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1102 Cardiorespiratory Medicine and Haematology